Guselkumab Succeeds for TNF Failures in Psoriatic Arthritis
(MedPage Today) -- Patients with psoriatic arthritis who had been treated unsuccessfully with one or more tumor necrosis factor (TNF) inhibitors showed high rates of efficacy with guselkumab (Tremfya) treatment, a phase IIIb study found.
At week...
Read more »